Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. (8AT)

Market Open
2 Mar, 07:10
XFRA XFRA
2. 41
-0.2
-7.66%
- Market Cap
- P/E Ratio
- Div Yield
2,000 Volume
-1.64 Eps
2.61
Previous Close
Day Range
2.41 2.41
Year Range
0.96 3.81
Want to track 8AT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
8AT earnings report is expected in 65 days (7 May 2026)
Name Time Cons. EPS Eps
Aclaris Therapeutics, Inc. logo
8AT Aclaris Therapeutics, Inc.
7 May 2026 (In 2 months)
-
-
Aclaris Therapeutics, Inc. logo
8AT Aclaris Therapeutics, Inc.
26 Feb 2026
-
-
Aclaris Therapeutics, Inc. logo
8AT Aclaris Therapeutics, Inc.
21 Feb 2024
-
-
Aclaris Therapeutics, Inc. logo
8AT Aclaris Therapeutics, Inc.
6 Nov 2023
-
-

8AT Earnings Reports FAQ

What is the earnings per share (EPS) for 8AT?

The current EPS is -1.64.

What is the company's earnings growth rate?

Aclaris Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-05-07, based on the 8AT's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Aclaris Therapeutics, Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 8AT at this time, as Aclaris Therapeutics, Inc has no recent EPS data to calculate it.